Sarene Koh

Dr. Koh was an A*STAR scholar and obtained her PhD in Medical Science from Karolinska Institute, Sweden in 2013. She was a post-doctoral fellow in the laboratory of Professor Antonio Bertoletti at Singapore Institute for Clinical Sciences (SICS) of A*STAR. Her current R&D and product development interests are focused on T-cell immunotherapy and the immuno-pathogenesis of hepatitis B virus infection. Since 2017, she has led Lion TCR's efforts on product development and process optimisation in T cell immuno-therapy and the immuno-pathogenesis of hepatitis B virus infection.